IQVIA Gets CDSCO Panel Nod To Study AVT06 biosimilar candidate to Eylea Dr. Divya Colin9 Oct 2022 1:40 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted permission to the...
JnJ gets CDSCO Panel nod to study antipsychotic drug Paliperidone Palmitate Dr. Divya Colin29 Sept 2022 6:00 PM ISTNew Delhi: Pharmaceutical major, Johnson and Johnson has got a go ahead from the Subject Expert Committee SEC functional under Central Drug Standard...
NovoNordisk Gets CDSCO Panel Nod To Study anti-diabetic FDC Cagrilinitide,Semaglutide Dr. Divya Colin19 Sept 2022 6:00 PM ISTNew Delhi: Advising to submit the trial safety and efficacy data, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
CDSCO panel seeks justification for Pfizer Phase III CT of 20-Valent Pneumococcal Conjugate Vaccine Dr. Divya Colin11 Sept 2022 11:35 AM ISTNew Delhi: In response to the drug major Pfizer's Phase III clinical trial proposal for Pneumococcal Polysaccharide Conjugate Vaccine (20 Valent), the...
Ultra rapid lispro in basal-bolus regimen bests lispro for PPG control in type 2 diabetes Dr. Kamal Kant Kohli30 Aug 2022 9:00 AM ISTUltra rapid lispro (URLi) is a novel formulation of insulin lispro designed to more closely match the physiological insulin response to a meal, with...
Intas Pharma Gets CDSCO Panel Okay To Study Human Normal Immunoglobulin Dr. Divya Colin25 July 2022 6:00 PM ISTNew Delhi: Pharmaceutical major Intas Pharma has got the go-head from the Subject Expert Committee (SEC) functional under Central Drug Standard...
Nonhormonal vaginal gel exhibits significant contraception in Phase 3 AMPOWER Clinical Trial Dr. Kamal Kant Kohli6 July 2022 10:45 AM ISTAccording to findings from a post hoc analysis of the registrational phase 3 AMPOWER trial, use of Phexxi® (lactic acid, citric acid, potassium...
Exhalation delivery system reduces inflammation of nasal cavity and symptoms of chronic sinusitis Dr. Kamal Kant Kohli17 Jun 2022 7:30 PM ISTAn exhalation delivery system that uses fluticasone propionate nasal spray may reduce symptoms of chronic sinusitis and local inflammation of the...
Roflumilast foam useful in patients with moderate to severe seborrheic dermatitis, reveals phase 3 trial Dr. Kamal Kant Kohli12 Jun 2022 7:30 PM ISTWESTLAKE VILLAGE, Calif: Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing meaningful...
New drug combination improves survival for some with lung cancer Dr. Kamal Kant Kohli4 Jun 2022 6:45 AM ISTPatients with advanced non-small cell lung cancer whose cancer had progressed on previous immunotherapy lived significantly longer when subsequently...
Evinacumab significantly lowers LDL C in kids with homozygous familial hypercholesterolemia Dr. Kamal Kant Kohli1 Jun 2022 10:00 AM ISTEvinacumab is a fully-human monoclonal antibody that binds to and blocks the function of angiopoietin-like 3 (ANGPTL3). According to findings from a...
Investigational JAK inhibitor found safe, effective in moderate to severe alopecia areata in phase 3 study Dr. Kamal Kant Kohli26 May 2022 8:00 PM ISTAlopecia areata is an autoimmune disorder that results in patchy or complete scalp hair loss. CTP-543 is an investigational oral selective inhibitor...
